Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 6, 1999, Pages 1036-1044

  Christodoulopoulos, Pota ^a   Wright, Erin ^b   Frenkiel, Saul ^b,c   Luster, Andrew ^d   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Massachusetts Gen Hosp Infect D   (United States)

Author keywords

Allergic rhinitis; Chemokines; Eosinophils; Monocyte chemotactic proteins; Topical corticosteroids

Indexed keywords

ALLERGEN; BUDESONIDE; CORTICOSTEROID; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4;

ALLERGIC RHINITIS; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; HELPER CELL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; MEDIATOR RELEASE; MONOCYTE; NOSE MUCOSA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION;

EID: 0032802386     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70176-4     Document Type: Article

References (28)

1. 1. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AMA, Schwartz LB, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992;146:170-6.
2. 2. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC-chemokines. Adv Immunol 1994;55:97-179.
3. 3C motif. Nature 1997;385:640-4.
4. 4. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.
5. 5. Rajakulasingam K, Hamid Q, O'Brien F, Shotman E, Jose PJ, Williams TJ, et al. Rantes in allergen-induced rhinitis. Cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med 1997;155:696-703.
6. 6. Minshall EM, Cameron L, Lavigne F, Leung DYM, Hamilos D, Garcia-Zepeda A, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
7. 7. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
8. 8. Garcia-Zepeda EA, Rothenberg ME, Owmbey RT, Celstin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
9. 9. Garcia-Zepeda EA, Combardiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, et al. Human monocyte chemoattractant protein (MCP-4) is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 1996;157:5613-26.
10. 10. Van Damme J, Proosr P, Put W, Arens S, Lenaerts JP, Conings R, et al. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. J Immunol 1995;152:5495-502.
11. 11. Shyy YJ, Hsieh HJ, Usami S, Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein-1 gene expression in vascular endothelium. Proc Natl Acad Sci USA 1994;91:4678-82.
12. 12. Izumi S, Hirai K, Miyamasu M, Takahashi Y, Misaki Y, Takaishi T, et al. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur J Immunol 1997;27:816-24.
13. 13. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1995;91:3652-6.
14. 14. Noso N, Proost P, Van Damme J, Schroder J. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994;200:1470-6.
15. 15. Loetscher P, Seitz M, dark-Lewis I, Baggiolini M, Moser B. Monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 1994;8:1055-60.
16. 16. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay BA, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-9.
17. 17. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay BA, et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cylokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. 1994. Immunology 1994;82:192-9.
18. 18. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
19. 19. Moqbel R, Ying Y, Barkans J, Newman TM, Kimmitt P, Wakelin M, et al. Identification of messenger RNA for IL-4 in human eosinophils with granular localization and release of the translated product. J Immunol 1995;155:4939-47.
20. 20. Ying S, Durham SR, Jacobson MR, Rak S, Masuyama K, Lowhagen O. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
21. 21. Lamkhioued B, Renzi P, Abi-Younes S, Garcia-Zepeda EA, Allakhverdi Z, Ghaffar O, et al. Increased expression of eotaxin in bronchial lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
22. 22. Wright E, Frenkiel S, Ghaffar O, Al-Ghamdi K, Small P, Hamid Q. Monocyte chemotactic protein expression in allergy and non-allergy-associated chronic sinusitis. J Otolaryngol 1998;27:281-7.
23. 23. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-33.
24. 24. Godiska R, Chantry D, Raport CJ, Schweickarrt VL, Trong HL, Gray PW. Monocyte chemotactic protein-4: tissue-specific expression and signalling through CC chemokine receptor-2. J Leukoc Biol 1997;61:353-60.
25. 25. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-I in human pleural fluids. J Immunol 1993;151:7216-23.
26. 26. Ylä-Hertuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, et al. Expression of monocyte chemotactic protein 1 in macrophage-rich areas of human rabbit atherosclerotic lesions. Proc Natl acad Sci USA 1991;88:5252-6.
27. 27. Ponath PD, Qin S, Ringer DJ, Clark-Lewis I, Wang J, Kassam N, et al. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996;97:604-12.
28. 28. Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, et al. Production of the novel C-C chemokine MCP-4 from airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-36.